Only a limited number of cases have demonstrated concurrent JAK2 and MPL mutations, which have been associated with myelodysplastic/MPNs, polycythemia vera, and essential thrombocythemia [6–8, 10]. The gene discussed is JAK2; the disease is acquired polycythemia vera.